Serdexmethylphenidate
KP1077.D01
Phase 2 small_molecule completed
Quick answer
Serdexmethylphenidate for Idiopathic Hypersomnia is a Phase 2 program (small_molecule) at ZEVRA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ZEVRA THERAPEUTICS, INC.
- Indication
- Idiopathic Hypersomnia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed